1 report

  • TAIMED BIOLOGICS ENTERS INTO LICENSING AGREEMENT WITH AMBRILIA BIOPHARMA

HIV Antiviral Portfolio. "

  • HIV AIDS
  • HIV Antiviral
  • United States
  • Product Initiative
  • TaiMed Biologics Inc.